KCNJ10 and myeloid sarcoma: In order to resolve the controversy regarding whether KIR4.1 autoantibodies are present in MS patients, two additional studies from independent groups performed the whole-KIR4.1-based ELISA and published their results in the New England Journal of Medicine in 2016.